Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited 0512.HK Peers
See (0512.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0512.HK | HK$8.90 | -2.63% | 31.2B | 12.71 | HK$0.70 | +5.84% |
| 3692.HK | HK$27.30 | +3.02% | 162.3B | 34.13 | HK$0.80 | N/A |
| 2196.HK | HK$16.60 | +3.75% | 67.2B | 13.83 | HK$1.20 | +1.97% |
| 0874.HK | HK$17.92 | +1.13% | 45.7B | 9.90 | HK$1.81 | +7.71% |
| 1513.HK | HK$29.85 | +2.40% | 34B | 11.94 | HK$2.50 | +5.43% |
| 3320.HK | HK$5.28 | +2.13% | 33.2B | 9.10 | HK$0.58 | +2.78% |
| 3933.HK | HK$15.48 | +0.91% | 28.1B | 9.74 | HK$1.59 | +3.97% |
| 0867.HK | HK$10.52 | -1.87% | 25.4B | 14.41 | HK$0.73 | +3.02% |
| 0013.HK | HK$23.70 | +2.16% | 20.7B | 76.45 | HK$0.31 | N/A |
| 9989.HK | HK$5.19 | -0.38% | 18.4B | 10.81 | HK$0.48 | +4.80% |
Stock Comparison
0512.HK vs 3692.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 3692.HK has a market cap of 162.3B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 3692.HK trades at HK$27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 3692.HK's P/E ratio is 34.13. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 3692.HK's ROE of +0.15%. Regarding short-term risk, 0512.HK is more volatile compared to 3692.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 2196.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 2196.HK has a market cap of 67.2B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 2196.HK trades at HK$16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 2196.HK's P/E ratio is 13.83. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 2196.HK's ROE of +0.06%. Regarding short-term risk, 0512.HK is less volatile compared to 2196.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0874.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0874.HK has a market cap of 45.7B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0874.HK trades at HK$17.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0874.HK's P/E ratio is 9.90. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0874.HK's ROE of +0.07%. Regarding short-term risk, 0512.HK is more volatile compared to 0874.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1513.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1513.HK has a market cap of 34B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1513.HK trades at HK$29.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1513.HK's P/E ratio is 11.94. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1513.HK's ROE of +0.15%. Regarding short-term risk, 0512.HK is more volatile compared to 1513.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 3320.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 3320.HK has a market cap of 33.2B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 3320.HK trades at HK$5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 3320.HK's P/E ratio is 9.10. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 3320.HK's ROE of +0.07%. Regarding short-term risk, 0512.HK is more volatile compared to 3320.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 3933.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 3933.HK has a market cap of 28.1B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 3933.HK trades at HK$15.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 3933.HK's P/E ratio is 9.74. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 3933.HK's ROE of +0.19%. Regarding short-term risk, 0512.HK is more volatile compared to 3933.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0867.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0867.HK has a market cap of 25.4B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0867.HK trades at HK$10.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0867.HK's P/E ratio is 14.41. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0867.HK's ROE of +0.09%. Regarding short-term risk, 0512.HK is more volatile compared to 0867.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0013.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0013.HK has a market cap of 20.7B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0013.HK trades at HK$23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0013.HK's P/E ratio is 76.45. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0013.HK's ROE of -0.01%. Regarding short-term risk, 0512.HK is more volatile compared to 0013.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 9989.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 9989.HK has a market cap of 18.4B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 9989.HK trades at HK$5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 9989.HK's P/E ratio is 10.81. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 9989.HK's ROE of +0.05%. Regarding short-term risk, 0512.HK is more volatile compared to 9989.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1558.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1558.HK has a market cap of 12B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1558.HK trades at HK$13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1558.HK's P/E ratio is 23.30. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1558.HK's ROE of +0.06%. Regarding short-term risk, 0512.HK is less volatile compared to 1558.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 6600.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 6600.HK has a market cap of 11.8B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 6600.HK trades at HK$18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 6600.HK's P/E ratio is 10.12. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 6600.HK's ROE of +0.36%. Regarding short-term risk, 0512.HK is more volatile compared to 6600.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0570.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0570.HK has a market cap of 11.3B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0570.HK trades at HK$2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0570.HK's P/E ratio is 225.00. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0570.HK's ROE of +0.00%. Regarding short-term risk, 0512.HK is more volatile compared to 0570.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 6185.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 6185.HK has a market cap of 10.5B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 6185.HK trades at HK$34.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 6185.HK's P/E ratio is -20.54. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 6185.HK's ROE of -0.07%. Regarding short-term risk, 0512.HK is more volatile compared to 6185.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1681.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1681.HK has a market cap of 9.7B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1681.HK trades at HK$11.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1681.HK's P/E ratio is 9.36. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1681.HK's ROE of +0.23%. Regarding short-term risk, 0512.HK is less volatile compared to 1681.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0460.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0460.HK has a market cap of 9.5B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0460.HK trades at HK$1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0460.HK's P/E ratio is -34.33. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0460.HK's ROE of -0.05%. Regarding short-term risk, 0512.HK is less volatile compared to 0460.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0719.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0719.HK has a market cap of 9.5B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0719.HK trades at HK$6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0719.HK's P/E ratio is 9.18. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0719.HK's ROE of +0.09%. Regarding short-term risk, 0512.HK is more volatile compared to 0719.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 2005.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 2005.HK has a market cap of 8.4B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 2005.HK trades at HK$2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 2005.HK's P/E ratio is 7.89. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 2005.HK's ROE of +0.15%. Regarding short-term risk, 0512.HK is more volatile compared to 2005.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 2877.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 2877.HK has a market cap of 5.7B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 2877.HK trades at HK$7.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 2877.HK's P/E ratio is 6.26. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 2877.HK's ROE of +0.11%. Regarding short-term risk, 0512.HK is more volatile compared to 2877.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 6896.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 6896.HK has a market cap of 3.9B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 6896.HK trades at HK$5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 6896.HK's P/E ratio is 11.28. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 6896.HK's ROE of +0.23%. Regarding short-term risk, 0512.HK is more volatile compared to 6896.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 2552.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 2552.HK has a market cap of 3B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 2552.HK trades at HK$3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 2552.HK's P/E ratio is -11.22. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 2552.HK's ROE of +2.97%. Regarding short-term risk, 0512.HK is less volatile compared to 2552.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1061.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1061.HK has a market cap of 2.8B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1061.HK trades at HK$4.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1061.HK's P/E ratio is 9.32. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1061.HK's ROE of +0.15%. Regarding short-term risk, 0512.HK is less volatile compared to 1061.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 2633.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 2633.HK has a market cap of 2.6B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 2633.HK trades at HK$1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 2633.HK's P/E ratio is 10.15. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 2633.HK's ROE of +0.11%. Regarding short-term risk, 0512.HK is more volatile compared to 2633.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 2161.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 2161.HK has a market cap of 2.1B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 2161.HK trades at HK$2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 2161.HK's P/E ratio is 12.75. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 2161.HK's ROE of +0.17%. Regarding short-term risk, 0512.HK is more volatile compared to 2161.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 2348.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 2348.HK has a market cap of 1.8B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 2348.HK trades at HK$1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 2348.HK's P/E ratio is 3.00. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 2348.HK's ROE of +0.17%. Regarding short-term risk, 0512.HK is less volatile compared to 2348.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 8049.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 8049.HK has a market cap of 1.2B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 8049.HK trades at HK$2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 8049.HK's P/E ratio is 5.94. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 8049.HK's ROE of +0.08%. Regarding short-term risk, 0512.HK is more volatile compared to 8049.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1349.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1349.HK has a market cap of 1B. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1349.HK trades at HK$3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1349.HK's P/E ratio is 78.00. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1349.HK's ROE of +0.02%. Regarding short-term risk, 0512.HK is less volatile compared to 1349.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0950.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0950.HK has a market cap of 847.9M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0950.HK trades at HK$1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0950.HK's P/E ratio is 9.00. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0950.HK's ROE of +0.06%. Regarding short-term risk, 0512.HK is more volatile compared to 0950.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0239.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0239.HK has a market cap of 754.2M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0239.HK trades at HK$2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0239.HK's P/E ratio is 9.68. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0239.HK's ROE of +0.11%. Regarding short-term risk, 0512.HK is more volatile compared to 0239.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0503.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0503.HK has a market cap of 750.6M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0503.HK trades at HK$1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0503.HK's P/E ratio is 13.77. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0503.HK's ROE of +0.07%. Regarding short-term risk, 0512.HK is less volatile compared to 0503.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 3737.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 3737.HK has a market cap of 683.4M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 3737.HK trades at HK$0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 3737.HK's P/E ratio is 6.75. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 3737.HK's ROE of +0.09%. Regarding short-term risk, 0512.HK is more volatile compared to 3737.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 3839.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 3839.HK has a market cap of 442.9M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 3839.HK trades at HK$1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 3839.HK's P/E ratio is 5.26. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 3839.HK's ROE of +0.05%. Regarding short-term risk, 0512.HK is more volatile compared to 3839.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0897.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0897.HK has a market cap of 405M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0897.HK trades at HK$0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0897.HK's P/E ratio is -36.00. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0897.HK's ROE of +0.00%. Regarding short-term risk, 0512.HK is less volatile compared to 0897.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0455.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0455.HK has a market cap of 301M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0455.HK trades at HK$0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0455.HK's P/E ratio is -4.67. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0455.HK's ROE of -0.15%. Regarding short-term risk, 0512.HK is more volatile compared to 0455.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1011.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1011.HK has a market cap of 293.3M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1011.HK trades at HK$0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1011.HK's P/E ratio is -1.98. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1011.HK's ROE of +0.14%. Regarding short-term risk, 0512.HK is more volatile compared to 1011.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 8329.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 8329.HK has a market cap of 281.9M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 8329.HK trades at HK$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 8329.HK's P/E ratio is 8.50. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 8329.HK's ROE of +0.03%. Regarding short-term risk, 0512.HK is more volatile compared to 8329.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1652.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1652.HK has a market cap of 255.1M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1652.HK trades at HK$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1652.HK's P/E ratio is -1.23. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1652.HK's ROE of -0.42%. Regarding short-term risk, 0512.HK is more volatile compared to 1652.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1498.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1498.HK has a market cap of 205.4M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1498.HK trades at HK$0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1498.HK's P/E ratio is -5.78. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1498.HK's ROE of -0.29%. Regarding short-term risk, 0512.HK is less volatile compared to 1498.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 8622.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 8622.HK has a market cap of 200.2M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 8622.HK trades at HK$0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 8622.HK's P/E ratio is -40.00. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 8622.HK's ROE of -0.08%. Regarding short-term risk, 0512.HK is less volatile compared to 8622.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 1312.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 1312.HK has a market cap of 161.8M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 1312.HK trades at HK$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 1312.HK's P/E ratio is -2.90. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 1312.HK's ROE of -0.07%. Regarding short-term risk, 0512.HK is less volatile compared to 1312.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0858.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0858.HK has a market cap of 117.1M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0858.HK trades at HK$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0858.HK's P/E ratio is 0.70. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0858.HK's ROE of +0.15%. Regarding short-term risk, 0512.HK is less volatile compared to 0858.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 0512.HK.
0512.HK vs 0911.HK Comparison
0512.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0512.HK stands at 31.2B. In comparison, 0911.HK has a market cap of 32.5M. Regarding current trading prices, 0512.HK is priced at HK$8.90, while 0911.HK trades at HK$0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0512.HK currently has a P/E ratio of 12.71, whereas 0911.HK's P/E ratio is 19.20. In terms of profitability, 0512.HK's ROE is +0.15%, compared to 0911.HK's ROE of +0.00%. Regarding short-term risk, 0512.HK is more volatile compared to 0911.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 0512.HK.